![Sarah Browne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sarah Browne
Chief Tech/Sci/R&D Officer at
METAVIA INC.
Net worth: 83 210 $ as of 2026-09-29
Profile
Dr. Sarah K.
Browne, MD, is a Chief Medical Officer at MetaVia, Inc. Dr. Browne was previously employed as a Vice President-Clinical Development by Altimmune, Inc. She received her undergraduate degree from Williams College and a doctorate degree from Virginia Commonwealth University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
METAVIA INC. 0.8% | 2026-10-11 | 53,000 ( 0.8% ) | 83 210 $ | 2026-09-29 |
Sarah Browne active positions
| Companies | Position | Start |
|---|---|---|
| METAVIA INC. | Chief Tech/Sci/R&D Officer | 2026-10-11 |
Former positions of Sarah Browne
| Companies | Position | End |
|---|---|---|
| ALTIMMUNE, INC. | Chief Tech/Sci/R&D Officer | 2025-03-31 |
Education of Sarah Browne
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Virginia Commonwealth University
 Virginia Commonwealth University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Williams College
 Williams College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altimmune, Inc.
 Altimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
NeuroBo Pharmaceuticals, Inc.
 NeuroBo Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops disease-modifying therapies for neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Sarah Browne
